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Magnetic nanoparticles show remarkable phenomena such as 
superparamagnetism, high field irreversibility and high saturation 
magnetization [1]. The study of magnetic nanoparticles has been a 
very active research field due to many important applications such 
as drug delivery, imaging and hyperthermia cancer treatment [2]. 
Hyperthermia has been used for many years to treat a wide variety of 
tumors in patients and used as well as an adjunct to cancer radiotherapy 
or chemotherapy [3,4]. Its use is based on the fact that tumor cells are 
more sensitive to temperature in the range of 42–45°C (which yields 
necrosis, coagulation, or carbonization) than normal tissue cells. 
This temperature range has become critical for cancer treatment due 
to damaging the cancerous cells without altering the healthy cells by 
selective heating (up to 45°C) and controlling heating rate and time. 
Basically, hyperthermia increases perfusion and oxygenation 
of neoplastic hypoxic cells, which are more resistant to ionizing 
radiation than normal cells [5]. Moreover, increased tumor tissue 
perfusion facilitates the absorption of chemotherapeutic drugs 
through cell membrane without being more toxic [6-8]. As a result, 
the action of combination of hyperthermia with radiotherapy or 
chemotherapy becomes more efficient. Consequently, hyperthermia 
allows reducing of tumors resistant to various chemotherapeutic 
drugs such as doxorubicin, cisplatin, bleomycin, nitrosoureas, and 
cyclophosphamide. It has been demonstrated that hyperthermia also 
has an anti-angiogenic action and an immunotherapeutic role, due to 
thermal shock proteins, which are produced by stressed tumor cells 
[9,10]. This method has found clinical application mostly in Europe 
and Asia [4,8]. While in the United States, microwave hyperthermia in 
conjunction with radiation has received approval from the Food and 
Drug Administration (FDA), it still remains mostly as an experimental 
method due to possible overheating and necrosis of normal tissue 
[11,12]. There is an urgent need for development of new hyperthermia 
heating agents and treatment methodologies that will be more effective 
than those currently available and help to unlock the full potential of 
the technology that can have a significant impact on management of 
cancer patients. Thus, it is of paramount importance to develop new 
nanostructured media, which would enable selective heating of tumor 
cells and vasculature avoiding excessive damage to healthy tissue 
structures.
Magnetic fluids based on iron oxide (Fe3O4), stabilized by 
biocompatible surfactants are typically used as heating agent in 
magnetic hyperthermia [13,14]. In the presence of AC magnetic 
field, magnetic nanoparticles show three different types of losses 
- Hysteresis, Ne´el, and Brownian, which are responsible for heat 
generation. However, significant limitations of using commercial 
available magnetic nanoparticles are non-selectivity and overheating 
of surrounding normal tissues. For most nanoparticles suggested so 
far for cancer hyperthermia treatment, uniform controlled induction 
heating and selectivity remain as major challenges. 
There is increasing number of research articles for self-controlled 
hyperthermia and development of nanoparticles with Curie 
Temperature (Tc) in the range of 45-50°C that are not affected by 
alternating magnetic fields above 50°C in order to prevent overheating 
of normal cells [15-26]. Various nanoparticles were synthesized using 
physical as well as chemical methods. For example, ultrafine alumina 
coated particles of substituted ferrite Co1−xZnxFe2O4 and yttrium–
iron garnet Y3Fe5−xAlxO12 have been proposed to tailor Tc at ~50°C 
[16]. Copper nickel (CuNi) alloy nanoparticles with varying Tc from 
40 to 60°C were synthesized by several techniques [17]. In vitro and 
in vivo animal experiments have demonstrated the feasibility of the 
temperature-controlled heating of the tissue, laden with the particles, 
by an external alternating magnetic field. Nickel-Chromium (Ni1-
xCrx) particles with varying compositions have been investigated as 
thermoseeds for use in localized self controlled hyperthermia treatment 
of cancer [18]. A series of Ni-Cr alloys, have been prepared to find the 
specific composition that has Curie temperature in range of 43-44°C. 
The samples were cast by arc melting technique then annealed at 850°C 
for 5 hours in sealed quartz tubes. The Curie temperatures of the alloys 
decreased almost linearly with increasing Cr concentration from 4.54 
to 5.9 wt %. The results showed that Ni1-xCrx alloys might be good 
candidates for self controlled magnetic hyperthermia applications.
Structural and magnetic properties have been studied for Gd5(Si1−
xGex)4 and (Gd1−xRx)5Si4 series, with R = Ce Nd, Er, and Ho, in the 
context of their use as magnetic materials in the self-controlled 
hyperthermia treatment of cancer [19]. The study shows that these 
materials have high magnetization values and their magnetic ordering 
temperatures can be varied linearly over a broad range by adjusting 
the composition of the constituent elements. The high magnetization 
and optimal Tc values of these composites meets self-controlled 
hyperthermia requirements. 
La-Ag and La-Na perovskite manganites were proposed [20] as 
smart mediators for self-controlled isothermal heating in magnetic 
hyperthermia. It shows that dissipation of the alternating magnetic 
field energy causes heating of aqueous suspensions to terminate 
at 42-48°C without external temperature control. Ferromagnetic 
La0.73Sr0.27MnO3 nanoparticles (20–100 nm) showed saturation 
magnetization  ~38 emu/g at 20 kOe with TC value of 45°C [21]. 
Unaggregated La0.82Sr0.18MnO3+δ perovskite nanoparticles with a mean 
crystallite size of 22 nm were successfully synthesized through an 
aqueous combustion synthesis, which takes advantage of exothermic, 
fast and self-sustaining chemical reactions between metal nitrates 
and glycine [22]. Fast calcination and milling process were used to 
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enhance crystallinity of the nanoparticles and their desaggregation. The 
heating experiments of magnetic fluid suspended La0.82Sr0.18MnO3+δ 
nanoparticles in AC magnetic field demonstrated that the particles can 
be used for self-controlled hyperthermia application, considering their 
maximum heating temperature ~43°C. Recently, it was shown that 
complex ferrites nanoparticles with formula Mg1+xFe2-2xTixO4, (where 
0≤x≤0.5) can be meet self-controlled hyperthermia requirements with 
Tc in range of 45-50°C [23-24]. Furthermore, authors [25] confirmed 
that Curie temperature for Zn doped Mn-ferrite, Mn1-xZnxO and 
the Gd doped Zn-ferrite, ZnGdxFe2-xO4 nanoparticles can be tuned 
to the optimum temperature of 43°C. The Mg-Fe-Ti compositions 
are very promising, since all the elements biocompatible. Magnetic 
nanocomposite Ni0.2Ca0.8Gd0.08Fe1.92O4 encapsulated by poly vinyl 
alcohol and synthesized by a two steps chemical reaction including sol-
gel combustion and solvent casting technique also can be applicable for 
self controlled hyperthermia [26].  
Thus, the magnetic materials with Curie temperature ~45°C, 
having sufficient biocompatibility are the best candidates for effective 
cancer hyperthermia treatment to avoid overheating. Because of 
unique capability of turning on and off the magnetic properties 
depending on temperature, the tumors will be continuously heated 
at a self-controlled temperature equal to the Curie temperature of 
the magnetic nanoparticles. This approach will allow to heat the 
tumor cells and vasculature selectively and to prevent overheating 
with subsequent damage to neighboring healthy tissues. Additionally, 
the self-controlled method might allow in situ MRI monitoring and 
selective hyperthermic therapy. 
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